CD4 and cancer: Our analysis showed that a large fraction of immune cell types were highly enriched in cancer, including follicular helper T cells (26/34), CD8+ T cells (25/34), M1 macrophages (23/34), M2 macrophages (28/34), CD4+ memory resting T cells (24/34), activated NK cells (21/34), and regulatory T cells (24/34).